Loading insider details...
Latest Form 4 (Nov 13, 2026): Grant/Award of 3,935 GRI shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 13, 2026 | GRI Bio, Inc. (GRI) | Grant/Award | 3,935 | n/a |
| Sep 22, 2025 | GRI Bio, Inc. (GRI) | Grant/Award | 23,605 | n/a |
| Aug 27, 2025 | GRI Bio, Inc. (GRI) | Grant/Award | 5,994 | n/a |
| Aug 14, 2025 | GRI Bio, Inc. (GRI) | Grant/Award | 4,527 | n/a |
| Jan 24, 2025 | GRI Bio, Inc. (GRI) | Grant/Award | 30,297 | $20.8K |
| Aug 14, 2023 | GRI BIO, Inc. (GRI) | Grant/Award | 34,483 | $100.0K |
| Mar 1, 2022 | Vallon Pharmaceuticals, Inc. (VLON) | Grant/Award | 61,000 | $343.4K |
| May 18, 2021 | Vallon Pharmaceuticals, Inc. (VLON) | Grant/Award | 100,000 | n/a |
| Feb 12, 2021 | Vallon Pharmaceuticals, Inc. (VLON) | Other (see footnotes) | 7,843 | $50.2K |